From the Journal

Heparin Versus Bivalirudin in ST-Segment Elevation Myocardial Infarction: A SCAI-Based National Survey From US Interventional Cardiologists

Harsh Golwala, MD1;  Sadip Pant, MD1;  Ambarish Pandey, MD2;  Michael P. Flaherty, MD, PhD1;  Glenn A. Hirsch, MD, MHS1;  Ajay J. Kirtane, MD, SM3


This survey was conducted to better understand current United States (US) practices in terms of preferences regarding the selection of antithrombotic therapy in STEMI-PPCI, particularly in light of recent clinical trials....

Intravenous Adenosine Infusion is Safe and Well Tolerated During Coronary Fractional Flow Reserve Assessment in Elderly Patients With Severe Aortic Stenosis

Dusan Stanojevic, MD1;  Prasad Gunasekaran, MD1;  Peter Tadros, MD1;  Mark Wiley, MD1;  Matthew Earnest, MD1; Ashwani Mehta, MD1;  Matthew Lippmann, MD2;  Micah Levine, MS3;  Buddhadeb Dawn, MD1;  Kamal Gupta, MD1 


Published online ahead of print on 2016 Jun 15

This study assessed the safety of intravenous adenosine infusion during fractional flow reserve evaluation of intermediate coronary lesions in severe aortic stenosis....

Outcomes After Orbital Atherectomy of Severely Calcified Left Main Lesions: Analysis of the ORBIT II Study

Michael S. Lee, MD1;  Evan Shlofmitz, DO2;  Richard Shlofmitz, MD3;  Sheila Sahni, MD1;  Brad Martinsen, PhD4;  Jeffrey Chambers, MD5

Published online ahead of print on 2016 Mar 15

This study evaluated the safety and efficacy of coronary orbital atherectomy to prepare severely calcified protected LM artery lesions for stent placement. ...

Ahead of Print

Right Heart Catheterization via Dialysis Arteriovenous Shunts in End-Stage Renal Disease Patients

Mu-Yang Hsieh, MD1;  Tsung-Yan Chen, MD1;  Lin Lin, MD1;  Min-Tsun Liao, MD1;  Ren-Huei Wang, RN1;  Ruei-Cheng Kuo, RT1;  Chao-Lun Lai, MD1,2,3,4,5;  Chih-Cheng Wu, MD1,3,4,6,7

Published online ahead of print on 2016 Sep 15

We evaluated the feasibility and safety of using dialysis AV shunts for access in right heart catheterization in 13 patients and found acceptable feasibility and patient tolerability. Further randomized studies are needed.

Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents – A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials

Anthony W.A. Wassef, MD1;  Hadi Khafaji, FRCPG1;  Ishba Syed1;  Andrew T. Yan, MD1;  Jacob A. Udell, MD, MPH2; Shaun G. Goodman, MD, MSc1;  Asim N. Cheema, MD, PhD1;  Akshay Bagai, MD, MHS1

Published online ahead of print on 2016 Sep 15

Current guidelines recommend 12 months of dual-antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation. We investigate whether the duration of DAPT can be safely shortened with use of second-generation DESs.


Comparison Between Radial Approach and Femoral Approach With Vascular Closure Devices on the Occurrence of Access-Site Complications and Periprocedural Bleeding After Percutaneous Coronary Procedures: A Systematic Review and Meta-Analysis

Stefano Rigattieri, MD, PhD1;  Alessandro Sciahbasi, MD1;  Karim Ratib, MD2;  Alessandro Alonzo, MD3;  Nicholas Cox, MD4;  Piotr Chodór, MD5;  Andrea Berni, MD3;  Silvio Fedele, MD1;  Francesco R. Pugliese, MD1;  Christopher J. Cooper, MD6;  Yves Louvard, MD7;  James Nolan, MD2;  Sunil V. Rao, MD8

Published online ahead of print on 2016 Sep 15

We performed a systematic review and meta-analysis of available studies comparing the efficacy of radial access vs femoral access with hemostasis by vascular closure device on the reduction of access-site complications and/or periprocedural bleedings.

International Andreas
Gruentzig Society

Back to top